SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.43-0.7%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DG30dk who wrote (1620)2/9/2007 9:55:19 AM
From: DG30dk   of 2240
 
I am surprised that there has not yet been any comments to this post addressing the issue of tax?

I deliberately kept tax out of the valuation because US corporations can carry forward net operating losses for 20 years for tax purposes. As we all know Medarex has accumulated sizeable net operating losses over the years so I do not expect them to pay much taxes.

In retrospect, however, I think I should perhaps have applied a 35% corporate tax rate and then make a valuation of Medarex's tax benefit from accumulated net operating losses. What is your opinion on this?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News